Future of "Big Pharma"

Subject: Pharmaceutical Industry. - "Big Pharma" Problem: The main problem is more than $80 billion worth of blockbuster drugs faces patent expiration by 2008. These drugs risk losing 80% or greater market share when generic copies hit the market. With the industry developing fewer blockbuster drugs today, it is of grave importance that pharmaceutical companies protect those drugs whose revenue streams will enable them to keep developing new medicines over the next decade . Alternatives: Line extension 2. Evergreening 3. New …

…www.cia.gov/cia/publications/factbook/geos/ch.html Cutting Edge Information, October 16, 2005 http://www.cuttingedgeinfo.com/ http://www.pharmamarketresearch.com/ Research and Markets, October 17, 2005 http://www.researchandmarkets.com/reportinfo.asp?report_id=988&cat_id=116 http://www.researchandmarkets.com/reportinfo.asp?report_id=41808 Institute For International Research, October 17, 2005 http://iirusa.com/generics/index.cfm Executive Meetings, October 17, 2005 http://www.economistconferences.com/roundtable/public/con_common.asp?rtid=720&rtRegion=2&area=1